APG Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $74.2M | Buy |
3,044,539
+103,340
| +4% | +$2.75M | 0.24% | 81 |
|
|
2025
Q4 | $62.4M | Sell |
2,941,199
-560,325
| -16% | -$14.1M | 0.18% | 98 |
|
|
2025
Q3 | $75.9M | Sell |
3,501,524
-1,033,141
| -23% | -$25.5M | 0.21% | 91 |
|
|
2025
Q2 | $93.6M | Buy |
4,534,665
+1,112,794
| +33% | +$26M | 0.28% | 67 |
|
|
2025
Q1 | $80.3M | Sell |
3,421,871
-2,197,342
| -39% | -$57.5M | 0.25% | 83 |
|
|
2024
Q4 | $144M | Buy |
5,619,213
+5,153,257
| +1,106% | +$140M | 0.4% | 55 |
|
|
2024
Q3 | $12.1M | Sell |
465,956
-4,436,821
| -90% | -$129M | 0.08% | 167 |
|
|
2024
Q2 | $128M | Sell |
4,902,777
-1,458,933
| -23% | -$40.2M | 0.23% | 103 |
|
|
2024
Q1 | $163M | Buy |
6,361,710
+135,472
| +2% | +$3.76M | 0.29% | 78 |
|
|
2023
Q4 | $162M | Buy |
6,226,238
+246,680
| +4% | +$7.46M | 0.32% | 75 |
|
|
2023
Q3 | $198M | Sell |
5,979,558
-900,960
| -13% | -$31.9M | 0.41% | 57 |
|
|
2023
Q2 | $231M | Buy |
6,880,518
+15,929
| +0.2% | +$620K | 0.47% | 47 |
|
|
2023
Q1 | $258M | Sell |
6,864,589
-651,121
| -9% | -$28.1M | 0.55% | 40 |
|
|
2022
Q4 | $385M | Buy |
7,515,710
+4,734,869
| +170% | +$227M | 0.73% | 30 |
|
|
2022
Q3 | $124M | Sell |
2,780,841
-456,751
| -14% | -$22.2M | 0.32% | 71 |
|
|
2022
Q2 | $162M | Sell |
3,237,592
-170,024
| -5% | -$8.66M | 0.38% | 69 |
|
|
2022
Q1 | $159M | Sell |
3,407,616
-463,976
| -12% | -$24.1M | 0.3% | 92 |
|
|
2021
Q4 | $201M | Buy |
3,871,592
+78,804
| +2% | +$3.9M | 0.34% | 83 |
|
|
2021
Q3 | $141M | Sell |
3,792,788
-177,588
| -4% | -$7.87M | 0.25% | 102 |
|
|
2021
Q2 | $131M | Sell |
3,970,376
-174,334
| -4% | -$6.78M | 0.22% | 119 |
|
|
2021
Q1 | $128M | Sell |
4,144,710
-2,378,373
| -36% | -$84.4M | 0.22% | 119 |
|
|
2020
Q4 | $196M | Sell |
6,523,083
-1,316,353
| -17% | -$48.3M | 0.32% | 74 |
|
|
2020
Q3 | $233M | Buy |
7,839,436
+170,802
| +2% | +$5.99M | 0.4% | 53 |
|
|
2020
Q2 | $212M | Buy |
7,668,634
+337,190
| +5% | +$11.5M | 0.39% | 57 |
|
|
2020
Q1 | $227M | Buy |
7,331,444
+4,136,150
| +129% | +$141M | 0.45% | 50 |
|
|
2019
Q4 | $106M | Buy |
3,195,294
+133,546
| +4% | +$4.76M | 0.17% | 156 |
|
|
2019
Q3 | $95.7M | Sell |
3,061,748
-10,533,461
| -77% | -$383M | 0.16% | 169 |
|
|
2019
Q2 | $491M | Sell |
13,595,209
-693,216
| -5% | -$27.5M | 0.84% | 19 |
|
|
2019
Q1 | $513M | Sell |
14,288,425
-2,955,416
| -17% | -$118M | 0.94% | 13 |
|
|
2018
Q4 | $625M | Buy |
17,243,841
+240,629
| +1% | +$9.99M | 1.27% | 6 |
|
|
2018
Q3 | $612M | Buy |
17,003,212
+1,182,588
| +7% | +$45.5M | 1.07% | 6 |
|
|
2018
Q2 | $466M | Buy |
15,820,624
+1,482,872
| +10% | +$50.7M | 0.86% | 14 |
|
|
2018
Q1 | $393M | Buy |
14,337,752
+2,181,780
| +18% | +$75M | 0.76% | 21 |
|
|
2017
Q4 | $348M | Sell |
12,155,972
-135,502
| -1% | -$4.62M | 0.64% | 27 |
|
|
2017
Q3 | $416M | Sell |
12,291,474
-2,358,114
| -16% | -$75.8M | 0.69% | 20 |
|
|
2017
Q2 | $467M | Sell |
14,649,588
-2,357,089
| -14% | -$74.3M | 0.85% | 17 |
|
|
2017
Q1 | $552M | Sell |
17,006,677
-5,649,161
| -25% | -$178M | 1.01% | 12 |
|
|
2016
Q4 | $662M | Sell |
22,655,838
-876,822
| -4% | -$26.8M | 1.24% | 6 |
|
|
2016
Q3 | $756M | Buy |
23,532,660
+896,743
| +4% | +$30M | 1.33% | 5 |
|
|
2016
Q2 | $756M | Buy |
22,635,917
+4,124,556
| +22% | +$132M | 1.42% | 4 |
|
|
2016
Q1 | $521M | Buy |
18,511,361
+1,663,170
| +10% | +$47.5M | 1.08% | 10 |
|
|
2015
Q4 | $516M | Buy |
16,848,191
+189,201
| +1% | +$5.95M | 1.19% | 8 |
|
|
2015
Q3 | $496M | Sell |
16,658,990
-103,622
| -0.6% | -$3.32M | 1.14% | 9 |
|
|
2015
Q2 | $533M | Buy |
16,762,612
+623,748
| +4% | +$20.3M | 1.07% | 8 |
|
|
2015
Q1 | $533M | Sell |
16,138,864
-1,960,965
| -11% | -$62.3M | 1.1% | 8 |
|
|
2014
Q4 | $535M | Sell |
18,099,829
-278,242
| -2% | -$7.98M | 1.03% | 9 |
|
|
2014
Q3 | $516M | Buy |
18,378,071
+587,006
| +3% | +$16.5M | 1.04% | 11 |
|
|
2014
Q2 | $501M | Buy |
17,791,065
+1,130,371
| +7% | +$32.2M | 1.07% | 8 |
|
|
2014
Q1 | $508M | Buy |
16,660,694
+706,148
| +4% | +$21.1M | 1.33% | 5 |
|
|
2013
Q4 | $464M | Buy |
15,954,546
+1,128,558
| +8% | +$32.8M | 1.36% | 5 |
|
|
2013
Q3 | $404M | Buy |
14,825,988
+3,540,575
| +31% | +$96.3M | 1.28% | 6 |
|
|
2013
Q2 | $300M | Buy |
+11,285,413
| New | +$312M | 0.94% | 15 |
|
Other funds holding PFE
VCM
VPM
APG Asset Management's PFE Position: Q1 2026 in Review
APG Asset Management increased its Pfizer (PFE) stake by 3.5% in Q1 2026, buying an estimated $2.75M and bringing the position to 3,044,539 shares worth $74.2M. The position accounts for 0.24% of the portfolio, ranked #81.
APG Asset Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $756M in Q3 2016. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- APG Asset Management held 3,044,539 shares of Pfizer worth $74.2M as of Q1 2026.
- APG Asset Management bought 103,340 Pfizer shares in Q1 2026, an estimated $2.75M.
- Pfizer made up 0.24% of APG Asset Management's portfolio in Q1 2026, its #81 holding.
- APG Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- APG Asset Management's Pfizer position peaked at $756M in Q3 2016.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on APG Asset Management's 13F filing for Q1 2026, filed 13 May 2026.